Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03104465
Other study ID # R34AT008423-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 30, 2017
Est. completion date June 11, 2018

Study information

Verified date July 2018
Source RTI International
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall aim of this study is to test the acceptability and feasibility of an interactive, web-based mindfulness training with active duty soldiers being treated for chronic pain.


Description:

The overall aim of study is to test the acceptability and feasibility of an interactive, web-based mindfulness training with active duty soldiers being treated for chronic pain. We will adapt the evidence-based Mindfulness-based Stress Reduction (MBSR) training for use with this population. The adapted training will be enhanced by mobile applications (apps) for skills practice, using an existing apps platform.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date June 11, 2018
Est. primary completion date June 11, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients who have experienced chronic pain for at least 6 months

Exclusion Criteria:

- Do not have any of the following conditions: substance abuse or dependence, psychosis, suicidal ideation in the last 2 months, high levels of trauma symptoms,

- plans to have a permanent change of station or deploy in the coming 6 months, or

- pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness Training
interactive. web-based mindfulness training complemented with mobile application

Locations

Country Name City State
United States Womack Army Medical Center at Ft. Bragg Fort Bragg North Carolina

Sponsors (2)

Lead Sponsor Collaborator
RTI International University of North Carolina, Chapel Hill

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Chronic Pain - Pain Intensity Assess pain intensity using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Pain Intensity 3a Baseline
Primary Chronic Pain - Pain Intensity Assess pain intensity using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Pain Intensity 3a 6 - 8 weeks post-treatment
Primary Chronic Pain - Pain Interference Assess pain intensity using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Pain Interference 8a Baseline
Primary Chronic Pain - Pain Interference Assess pain intensity using the Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Pain Interference 8a 6 - 8 weeks post-treatment
Primary Chronic Pain Assess intensity of sensory and affective pain using Short-Form McGill Pain Questionnaire Baseline
Primary Chronic Pain Assess intensity of sensory and affective pain using Short-Form McGill Pain Questionnaire 6 - 8 weeks post-treatment
Secondary Co-Occurring Conditions - Depression Assess depression using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Emotional Distress - Depression 8a Baseline
Secondary Co-Occurring Conditions - Depression Assess depression using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Emotional Distress - Depression 8a 6 - 8 weeks post-treatment
Secondary Co-Occurring Conditions - Anxiety Assess anxiety using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v1.0 - Emotional Distress- Anxiety 6a Baseline
Secondary Co-Occurring Conditions - Anxiety Assess anxiety using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v1.0 - Emotional Distress- Anxiety 6a 6 - 8 weeks post-treatment
Secondary Co-Occurring Conditions - Alcohol Use Assess hazardous and harmful alcohol use and dependence using the Alcohol Use Disorders Identification Test (AUDIT) Baseline
Secondary Co-Occurring Conditions - Alcohol Use Assess hazardous and harmful alcohol use and dependence using the Alcohol Use Disorders Identification Test (AUDIT) 6 - 8 weeks post-treatment
Secondary Co-Occurring Conditions - Post Traumatic Stress Disorder Assess trauma symptoms in response to stressful experiences using the Post Traumatic Stress Disorder (PTSD) Checklist - Civilian version (PCL-C) Baseline
Secondary Co-Occurring Conditions - Post Traumatic Stress Disorder Assess trauma symptoms in response to stressful experiences using the Post Traumatic Stress Disorder (PTSD) Checklist - Civilian version (PCL-C) 6 - 8 weeks post-treatment
Secondary Co-Occurring Conditions - Prescription drug misuse Assess use of drugs not prescribed, or use of more than recommended dose, to feel good/get high/buzzed Baseline
Secondary Co-Occurring Conditions - Prescription drug misuse Assess use of drugs not prescribed, or use of more than recommended dose, to feel good/get high/buzzed 6 - 8 weeks post-treatment
Secondary Quality of Life - Physical Functioning Assess physical functioning using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Physical Function 12a Baseline
Secondary Quality of Life - Physical Functioning Assess physical functioning using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Physical Function 12a 6 - 8 weeks post-treatment
Secondary Quality of Life - Sleep disturbance Assess sleep quality, depth and restoration using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Sleep Disturbance 8a Baseline
Secondary Quality of Life - Sleep disturbance Assess sleep quality, depth and restoration using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Sleep Disturbance 8a 6 - 8 weeks post-treatment
Secondary Quality of Life - Fatigue Assess fatigue using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Fatigue 8a Baseline
Secondary Quality of Life - Fatigue Assess fatigue using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Fatigue 8a 6 - 8 weeks post-treatment
Secondary Quality of Life - Role satisfaction Assess social satisfaction using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Ability to Participate in Social Roles & Activities 8a Baseline
Secondary Quality of Life - Role satisfaction Assess social satisfaction using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Ability to Participate in Social Roles & Activities 8a 6 - 8 weeks post-treatment
Secondary Self-Regulation - Pain Catastrophizing Scale Assess experience of pain through sub-scales of rumination, magnification and helplessness Baseline
Secondary Self-Regulation - Pain Catastrophizing Scale Assess experience of pain through sub-scales of rumination, magnification and helplessness 6 - 8 weeks post-treatment
Secondary Self-Regulation - Chronic Pain Acceptance Scale Assess behavioral aspects of chronic pain acceptance Baseline
Secondary Self-Regulation - Chronic Pain Acceptance Scale Assess behavioral aspects of chronic pain acceptance 6 - 8 weeks post-treatment
Secondary Self-Regulation - Emotional Behavioral Dysregulation Assess emotional behavioral dysregulation using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Emotional and Behavioral Dyscontrol Baseline
Secondary Self-Regulation - Emotional Behavioral Dysregulation Assess emotional behavioral dysregulation using Patient Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) v.1.0 - Emotional and Behavioral Dyscontrol 6 - 8 weeks post-treatment
Secondary Mindfulness Assess mindfulness using the Five Factor Mindfulness Questionnaire (FFMQ) Baseline
Secondary Mindfulness Assess mindfulness using the Five Factor Mindfulness Questionnaire (FFMQ) 6 - 8 weeks post-treatment
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain